Cyproheptadine

From Wikipedia, the free encyclopedia

Cyproheptadine
Systematic (IUPAC) name
4-(5 H-dibenzo [a,d]cyclohepten-5-ylidene)- 1 -methylpiperidine hydrochloride
Identifiers
CAS number 129-03-3
ATC code R06AX02
PubChem 2913
DrugBank APRD00033
Chemical data
Formula C21H21N 
Mol. mass 287.398 g/mol
Pharmacokinetic data
Bioavailability  ?
Protein binding 96 to 99%
Metabolism Hepatic and renal
Half life 1 to 4 hours
Excretion Fecal and renal
Therapeutic considerations
Pregnancy cat.

B(US)

Legal status

P(UK)

Routes Oral only

Cyproheptadine (usually as cyproheptadine hydrochloride, trade name Periactin) is an antihistaminic and antiserotonergic agent. It acts as a 5-HT2 receptor antagonist and also blocks calcium channels.

[edit] Uses

Cyproheptadine is used in the treatment of allergies (specifically hay fever) and is also used to stimulate appetite in underweight people (e.g. anorexia nervosa).

Cyproheptadine is used in serotonin syndrome, a complex of symptoms associated with selective serotonin reuptake inhibitors, especially when taken in excess dose, meperidine and in the disease carcinoid in which serotonin is overproduced by tumor cells.

Cyproheptadine is a useful alternative to benzodiazepine hypnotics in the treatment of insomnia. Cyproheptadine may be superior to benzodiazepines in the treatment of insomnia because cyproheptadine enhances sleep quality and quantity whereas benzodiazepines tend to decrease sleep quality.[1]

Recently, Cyproheptadine has also been prescribed to children and adolescents with frequent migranes.

[edit] Side effects

While not specifically used as a sedative, cyproheptadine causes sedation, likely due to its anti-histamine effects.[citation needed]

Digestive system: epigastric distress (dysphagia), loss of appetite, nausea, vomiting, (it is noted that these side effects are much more common in people with neuromuscular disorders)[citation needed]

Cyproheptadine can also cause Over Sleeping(10 Hours)in Children and Adolescents.

[edit] References

  1. ^ Tokunaga S; Takeda Y, Shinomiya K, Hirase M, Kamei C. (Feb 2007). "Effects of some H1-antagonists on the sleep-wake cycle in sleep-disturbed rats." (pdf). J Pharmacol Sci. 103 (2): 201–6. doi:10.1254/jphs.FP0061173. PMID 17287588. 
Languages